By: Erica Dimitropoulos Co-Copy Editor [Content- Focused] - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…
By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…
By: Neal Shah, Co Editor-In-Chief - Pure Red Cell Aplasia (PRCA), also known as erythroblastopenia, is characterized by a suppression…
By: Khilna Patel, Pharm.D. Candidate c/o 2012 - On October 25 of this year, Eli Lilly and Company announced a…